U.S. Treasury Proposes New Investment Limits for Chinese Biotech Firms

The U.S. Department of the Treasury has proposed adding biotechnology to a list of sensitive technologies subject to investment restrictions involving foreign adversaries. This move by the Trump administration aims to curb U.S. investment in Chinese biotechnology companies, citing national security concerns. It represents a further escalation in efforts to limit China's advancements in the biotech sector.